Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / FOLD - Assessing Amicus Therapeutics After Trial Results

FOLD - Assessing Amicus Therapeutics After Trial Results

Amicus Therapeutics Inc.
  • Recently, the shares of Amicus Therapeutics imploded as data from a late-stage study were disappointing.
  • However, the company plans to continue with a marketing application and Amicus has other assets that might be over discounted.
  • We revisit Amicus and provide a full investment analysis in the paragraphs below.

For further details see:

Assessing Amicus Therapeutics After Trial Results
Stock Information
Company Name: Amicus Therapeutics Inc.
Stock Symbol: FOLD
Market: NASDAQ
Website: amicusrx.com
Menu
FOLD FOLD Quote FOLD Short FOLD News FOLD Articles FOLD Message Board
Get FOLD Alerts

News, Short Squeeze, Breakout and More Instantly...